SGLT2 Inhibitors and Finerenone: A friendly Duo in the Treatment of Diabetic Kidney Disease?

Asirvatham AR, Asirvatham AJ, Mahadevan S

Open source

DOI
10.59556/japi.72.0759
Published
2024 Dec
Container
The Journal of the Association of Physicians of India
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.59556/japi.72.0759,
  title = {SGLT2 Inhibitors and Finerenone: A friendly Duo in the Treatment of Diabetic Kidney Disease?},
  author = {Asirvatham AR and Asirvatham AJ and Mahadevan S},
  year = {2024},
  journal = {The Journal of the Association of Physicians of India},
  doi = {10.59556/japi.72.0759},
  url = {https://doi.org/10.59556/japi.72.0759}
}

RIS

TY  - JOUR
TI  - SGLT2 Inhibitors and Finerenone: A friendly Duo in the Treatment of Diabetic Kidney Disease?
AU  - Asirvatham AR
AU  - Asirvatham AJ
AU  - Mahadevan S
PY  - 2024
JO  - The Journal of the Association of Physicians of India
DO  - 10.59556/japi.72.0759
UR  - https://doi.org/10.59556/japi.72.0759
ER  - 

APA

AR, A., AJ, A., & S, M. (2024). SGLT2 Inhibitors and Finerenone: A friendly Duo in the Treatment of Diabetic Kidney Disease?. The Journal of the Association of Physicians of India. https://doi.org/10.59556/japi.72.0759

Source records